Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New training cuts dialysis infections?

NCT ID NCT03816111

Disease control Sponsor: The University of Queensland Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a new training package called TEACH-PD could lower infection rates in patients starting peritoneal dialysis (PD). Over 1,400 adults from multiple countries were randomly assigned to receive either the TEACH-PD training or standard PD training. The researchers tracked infections like peritonitis and exit-site infections to see if the new approach made a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
TEACH-PD training curriculum (behavioral intervention)
What this could lead to
If successful, this training could reduce dangerous infections in people on peritoneal dialysis, making home dialysis safer and more widely used.
What could go wrong
This is a completed trial, but the intervention is a training program, not a drug or device. Its impact depends on consistent implementation across different clinics and patient populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,462 people

The number who actually took part.

Started

Jul 2019

Finished

Apr 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients new to PD; * Patients \> 18 years of age, * Need to undergo PD training; * Are able to provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for End-stage kidney disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome end stage renal failure infectious peritonitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Kidney disease, chronic Peritoneal dialysis catheter exit site infection Peritoneal dialysis catheter tunnel infection Peritoneal dialysis catheter-associated peritonitis

Contacts and locations

Locations

  • Auckland Hospital

    Auckland, New Zealand

  • Austin Health

    Heidelberg, Victoria, Australia

  • Barwon Health

    Geelong, Victoria, 3220, Australia

  • Cairns Hospital

    Cairns, Queensland, Australia

  • Canberra Hospital

    Canberra, Australian Capital Territory, Australia

  • Christchurch Hospital

    Christchurch, New Zealand

  • Dunedin Hospital

    Dunedin, New Zealand

  • Fiona Stanley Hospital

    Murdoch, Western Australia, 6150, Australia

  • Gisborne Hospital

    Gisborne, 4010, New Zealand

  • Gold Coast University Hospital

    Southport, Queensland, Australia

  • Gosford Hospital

    Gosford, New South Wales, Australia

  • Hawke's Bay Hospital

    Hastings, New Zealand

  • Launceston General Hospital

    Launceston, Tasmania, 7250, Australia

  • Lismore Hospital

    Lismore, New South Wales, Australia

  • Liverpool Hospital

    Sydney, New South Wales, Australia

  • Logan Hospital

    Meadowbrook, Queensland, Australia

  • Mackay Base Hospital

    Mackay, Queensland, 4740, Australia

  • Middlemore Hospital

    Auckland, New Zealand

  • Monash Health

    Dandenong, Victoria, Australia

  • Nelson Hospital

    Nelson, 7010, New Zealand

  • Nepean/Blacktown Hospital

    Sydney, New South Wales, Australia

  • North Shore Hospital

    Auckland, 0620, New Zealand

  • Orange Hospital

    Orange, New South Wales, Australia

  • Palmerston North/Whanganui Hospital

    Palmerston North, New Zealand

  • Prince of Wales Hospital

    Sydney, New South Wales, Australia

  • Princess Alexandra Hospital

    Brisbane, Queensland, Australia

  • Royal Adelaide Hospital

    Adelaide, South Australia, Australia

  • Royal Brisbane and Women's Hospital

    Herston, Queensland, 4029, Australia

  • Royal Darwin Hospital

    Darwin, Northern Territory, 0810, Australia

  • Royal Hobart Hospital

    Hobart, Tasmania, 7000, Australia

  • Royal Melbourne Hospital

    Melbourne, Victoria, Australia

  • Royal North Shore Hospital

    St Leonards, New South Wales, Australia

  • Royal Perth Hospital

    Perth, Western Australia, 6000, Australia

  • Royal Prince Alfred/Concord Hospital

    Sydney, New South Wales, Australia

  • Sir Charles Gairdner Hospital

    Nedlands, Western Australia, 6009, Australia

  • St George Hospital

    Sydney, New South Wales, Australia

  • St Vincent's Hospital Melbourne

    Fitzroy, Victoria, 3065, Australia

  • St Vincent's Hospital Sydney

    Darlinghurst, New South Wales, 2010, Australia

  • Sunshine Coast University Hospital

    Nambour, Queensland, Australia

  • Tamworth Hospital

    Tamworth, New South Wales, Australia

  • Taranaki Hospital

    New Plymouth, New Zealand

  • The Tweed Hospital

    Tweed Heads, New South Wales, 2485, Australia

  • Toowoomba Hospital

    Toowoomba, Queensland, Australia

  • Waikato Hospital

    Hamilton, 3204, New Zealand

  • Wairau Hospital

    Blenheim, 7201, New Zealand

  • Waitakere Hospital

    Auckland, 0610, New Zealand

  • Wellington Hospital

    Wellington, 6021, New Zealand

  • Whangarei Hospital

    Whangarei, New Zealand

More trials for these conditions

Other studies related to the condition(s) this trial covers.